KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2016 - 2017)

Teva Pharmaceutical Industries filings provide 3 years of Liabilities from Discontinued Operations readings, the most recent being 38000000.0 for Q4 2017.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 67.24% to 38000000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was 38000000.0, a 67.24% decrease, with the full-year FY2017 number at 38000000.0, down 67.24% from a year prior.
  • Liabilities from Discontinued Operations hit 38000000.0 in Q4 2017 for Teva Pharmaceutical Industries, roughly flat from 38000000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 327000000.0 in Q3 2016 to a low of 38000000.0 in Q3 2017.
  • Median Liabilities from Discontinued Operations over the past 3 years was 116000000.0 (2016), compared with a mean of 153120000.0.
  • The widest YoY moves for Liabilities from Discontinued Operations: up 67.24% in 2017, down 88.38% in 2017.
  • Teva Pharmaceutical Industries' Liabilities from Discontinued Operations stood at 246600000.0 in 2013, then crashed by 52.96% to 116000000.0 in 2016, then plummeted by 67.24% to 38000000.0 in 2017.
  • The last three reported values for Liabilities from Discontinued Operations were 38000000.0 (Q4 2017), 38000000.0 (Q3 2017), and 116000000.0 (Q4 2016) per Business Quant data.